245 related articles for article (PubMed ID: 22948843)
1. Comparison between living donor liver transplantation recipients who met the Milan and UCSF criteria after successful downstaging therapies.
Lei J; Yan L
J Gastrointest Surg; 2012 Nov; 16(11):2120-5. PubMed ID: 22948843
[TBL] [Abstract][Full Text] [Related]
2. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
Yao FY; Hirose R; LaBerge JM; Davern TJ; Bass NM; Kerlan RK; Merriman R; Feng S; Freise CE; Ascher NL; Roberts JP
Liver Transpl; 2005 Dec; 11(12):1505-14. PubMed ID: 16315294
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
[TBL] [Abstract][Full Text] [Related]
4. Comparison of hepatitis B prophylactic outcomes in living donor liver transplantation recipients who meet the Milan or UCSF criteria.
Jiang L; Yan LN; Wen TF; Li B; Yang JY
Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):494-9. PubMed ID: 24103279
[TBL] [Abstract][Full Text] [Related]
5. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
6. Outcome comparisons among the Hangzhou, Chengdu, and UCSF criteria for hepatocellular carcinoma liver transplantation after successful downstaging therapies.
Lei J; Yan L
J Gastrointest Surg; 2013 Jun; 17(6):1116-22. PubMed ID: 23325342
[TBL] [Abstract][Full Text] [Related]
7. Downstaging advanced hepatocellular carcinoma to the Milan criteria may provide a comparable outcome to conventional Milan criteria.
Lei J; Wang W; Yan L
J Gastrointest Surg; 2013 Aug; 17(8):1440-6. PubMed ID: 23719776
[TBL] [Abstract][Full Text] [Related]
8. Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy.
Lei JY; Yan LN; Wang WT
World J Gastroenterol; 2013 Jul; 19(27):4400-8. PubMed ID: 23885153
[TBL] [Abstract][Full Text] [Related]
9. Living donor liver transplantation or hepatic resection combined with intraoperative radiofrequency ablation for Child-Pugh A hepatocellular carcinoma patient with Multifocal Tumours Meeting the University of California San Francisco (UCSF) criteria.
Xu X; Pu X; Jiang L; Huang Y; Yan L; Yang J; Wen T; Li B; Wu H; Wang W
J Cancer Res Clin Oncol; 2021 Feb; 147(2):607-618. PubMed ID: 32852635
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
11. Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma: The Effectiveness of Different Particle Sizes in Downstaging and Bridging in Living Donor Liver Transplantation.
Lim WX; Sim KS; Chen CL; Ou HY; Yu CY; Cheng YF
Transplant Proc; 2024 Apr; 56(3):596-601. PubMed ID: 38472083
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma.
Unek T; Karademir S; Arslan NC; Egeli T; Atasoy G; Sagol O; Obuz F; Akarsu M; Astarcioglu I
World J Gastroenterol; 2011 Oct; 17(37):4206-12. PubMed ID: 22072852
[TBL] [Abstract][Full Text] [Related]
13. Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria.
Kim Y; Stahl CC; Makramalla A; Olowokure OO; Ristagno RL; Dhar VK; Schoech MR; Chadalavada S; Latif T; Kharofa J; Bari K; Shah SA
Surgery; 2017 Dec; 162(6):1250-1258. PubMed ID: 29033224
[TBL] [Abstract][Full Text] [Related]
14. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria).
Llovet JM; Pavel M; Rimola J; Diaz MA; Colmenero J; Saavedra-Perez D; Fondevila C; Ayuso C; Fuster J; Ginès P; Bruix J; Garcia-Valdecasas JC
Liver Transpl; 2018 Mar; 24(3):369-379. PubMed ID: 29140601
[TBL] [Abstract][Full Text] [Related]
16. Immediate radical therapy or conservative treatments when meeting the Milan criteria for advanced HCC patients after successful TACE.
Jiang L; Lei JY; Wang WT; Yan LN; Li B; Wen TF; Xu MQ; Yang JY; Wei YG
J Gastrointest Surg; 2014 Jun; 18(6):1125-30. PubMed ID: 24664424
[TBL] [Abstract][Full Text] [Related]
17. Surgical resection versus open-approach radiofrequency ablation for small hepatocellular carcinomas within Milan criteria after successful transcatheter arterial chemoembolization.
Lei J; Wang W; Yan L
J Gastrointest Surg; 2013 Oct; 17(10):1752-9. PubMed ID: 23959694
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
[TBL] [Abstract][Full Text] [Related]
19. Effect of Downstaging and Bridging of Hepatocellular Carcinoma on Survival Following Liver Transplant: A Single Center Experience.
Al Sebayel MI; Elsiesy H; Al-Hamoudi W; Alabbad S; ElSheikh Y; Elbeshbeshy H; Salih I; Yousif S; Saleh Y; Eldali A; Abaalkhail FA
Exp Clin Transplant; 2017 Mar; 15(Suppl 2):7-11. PubMed ID: 28301992
[TBL] [Abstract][Full Text] [Related]
20. Survival differences between Milan criteria after down-staging and De novo Milan in living donor liver transplantation for hepatocellular carcinoma.
Ahn CS; Moon DB; Lee SG; Hwang S; Kim KH; Ha TY; Song GW; Jung DH; Park GC; Park YH; Park HW; Jung BH; Kang SH
Hepatogastroenterology; 2014; 61(129):187-91. PubMed ID: 24895818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
